Skip to main content
Bruce Volpe, MD, Neurology, Manhasset, NY, Long Island Jewish Medical Center

BruceTVolpeMD

Neurology Manhasset, NY

Professor of Molecular Medicine, Feinstein Institute for Medical Research, Hofstra University Medical School, Northwell Health, EmeritusProfessor, Neurology & Neuroscience, Weill Cornell Medical College

Dr. Volpe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Volpe's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1976 - 1978
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1975 - 1976
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1973 - 1975
  • Yale School of Medicine
    Yale School of MedicineClass of 1973

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1974 - Present
  • NY State Medical License
    NY State Medical License 1975 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Neuromyelitis Optica Linked to Antibody Exposure During Fetal Development, Feinstein Institutes Study Finds
    Neuromyelitis Optica Linked to Antibody Exposure During Fetal Development, Feinstein Institutes Study FindsApril 20th, 2022
  • Feinstein Institutes Trial Finds Promising Non-Invasive Therapy for Stroke
    Feinstein Institutes Trial Finds Promising Non-Invasive Therapy for StrokeAugust 13th, 2019
  • PathMaker Neurosystems Announces Publication of First Clinical Trial Results for Its MyoRegulator® Device for Non-Invasive Treatment of Spasticity
    PathMaker Neurosystems Announces Publication of First Clinical Trial Results for Its MyoRegulator® Device for Non-Invasive Treatment of SpasticityJuly 25th, 2019
  • Join now to see all

Grant Support

  • Developmental Neurotoxicity: Maternal Anti-Nmdar Antibodies And Fetal DevelopmentNational Institute Of Allergy And Infectious Diseases2008–2011
  • Behavior/Histopathology Of Model Of Cerebral IschemiaNational Institute Of Mental Health1991–1992
  • Behavior/Histopathology Of Model Of Cerebral IschemiaNational Institute Of Mental Health1990
  • Behavior And Metabolism After Hippocampal InjuryNational Institute Of Mental Health1986–1988

Hospital Affiliations